ESCMID is pleased to welcome a new ESCMID Collaborative Centre in Beijing, China. Our members can visit the Peking Union Medical College Hospital via the ESCMID Observership Programme. Apply here
In May 2014 one ESCMID officer will be demitting office. The resulting vacancy is to be filled with one infectious disease specialist, who will serve for a four-year term starting in May during ECCMID. The election platform closes on 16 December.
Two open scientific surveys - thanks for your participation!
Two ESCMID Study Groups currently run scientific surveys and look forward to your participation:
ESCMID’s intention is to increase the number of ECCs outside Europe. Just recently ESCMID welcomed the University of Cape Town, South Africa (Division of Infectious Diseases & HIV) as a new ECC. Visit further ECCs outside Europe and to learn good clinical and/or laboratory practice: Centre Hospitalier Universitaire, Sousse, Tunisia.
For the first time, a Chinese-made vaccine receives World Health Organization endorsement. The vaccine – formally known as SA 14-14-2 – protects children against Japanese encephalitis, a viral brain infection common in parts of east and south Asia.
Other Chinese-made vaccines are on the same tracks, like Hecolin, a hepatitis E vaccine, that was presented – for the first time on European soil – at the ESCMID Conference on the Impact of Vaccines on Public Health earlier this year. The presentation is freely available on the ESCMID website.
If you are interested in the field of vaccinology, join EVASG, the ESCMID Vaccine Study Group.